악골골수염에서 분리된 연쇄상구균의 수종 항생제에 대한 감수성 조사

ANTIMICROBIAL SUSCEPTIBILITY IN STREPTOCOCCI SPP. BACTERIA ISOLATED FROM OSTEOMYELITIS OF THE JAWS

  • 임석균 (조선대학교 치과대학 구강악안면외과, 구강생물학연구소) ;
  • 김수관 (조선대학교 치과대학 구강악안면외과, 구강생물학연구소) ;
  • 김미광 (조선대학교 치과대학 구강생화학교실, 구강생물학연구소) ;
  • 국중기 (조선대학교 치과대학 구강생화학교실, 구강생물학연구소)
  • Lim, Suk-Kyun (Dept. of Oral & Maxillofacial Surgery, College of Dentistry, Oral Biology Research Institute, Chosun University) ;
  • Kim, Su-Gwan (Dept. of Oral & Maxillofacial Surgery, College of Dentistry, Oral Biology Research Institute, Chosun University) ;
  • Kim, Mi-Kwang (Dept. Oral Biochemistry, College of Dentistry, Oral Biology Research Institute, Chosun University) ;
  • Kook, Joong-Ki (Dept. Oral Biochemistry, College of Dentistry, Oral Biology Research Institute, Chosun University)
  • 발행 : 2004.06.30

초록

Previously, strains of Streptococci genera were isolated from osteomyelitis caused by the post-infection after extraction. In present study, to test the sensitivity of the Streptococci strains against seven antibiotics, penicillin G, amoxicillin, tetracycline, ciprofloxacin, cefuroxime, erythromycin, clindamycin, and vancomycin, minimum inhibitory concentration (MIC) was performed using broth dilution assay. Our data showed that the value of MIC of the Streptococci against antibiotics were different among the strains. In addition, the degree of resistance to antibiotics of Streptococci strains was mainly depended on the origin of isolation. Our results suggest that the development of the rapid and accurate method to detect the antibiotics-resistant bacteria is need to prevent the misuse or abuse of antibiotics and outbreak of antibiotics-resistant bacteria.

키워드

참고문헌

  1. Bernier S, Clermont S, Maranda G, Turcotte JY : Osteomyelitis of the jaws. J Can Dent Assoc 1995;61:441-442, 445-448
  2. 김미성, 김수관, 정해만, 김생곤, 국중기, 김미광, 김화숙, 유소영 : 분자생물학적 기법을 이용한 악골골수염 병소의 세균 동정. 대한구강악안면외과학회 2003;29(1):48-55
  3. Paster BJ, Boches SK, Galvin JL, Ericson RE, Lau CN, Levanos VA, Sahasrabudhe A, Dewhirst FE : Bacterial diversity in human subgingival plaque. J Bacteriol 2001;183(12):3770-3783 https://doi.org/10.1128/JB.183.12.3770-3783.2001
  4. Kim SG, Jang HS : Treatment of chronic osteomyelitis in Korea. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;92:394-398 https://doi.org/10.1067/moe.2001.117810
  5. Sambrook J, Fritsch EF, Maniatis T : Molecular cloning: a laboratory manual. Ed 2nd. Cold Spring Harbor Laboratory Press, 1988
  6. Murray PR, Jorgensen JH : Quantitative susceptibility test methods in major united states medical center. Antimicrobial agent and chemotherapy. 1981;20(1):66-70 https://doi.org/10.1128/AAC.20.1.66
  7. Jorgensen JH, Turnidge JD, Washington A : Antibacterial susceptibility tests: dilution and disk diffusion methods. In: Murray ER, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, Manual of CLINICAL MICROBIOLOGY. 7th ed. ASM press. Washington, 1999;1526-1543
  8. Roberts MC : Tetracycline resistance determinants: mechanisms of action, regulation of expression, genetic mobility, and distribution. FEMS Microbiol Rev 1996;19(1):1-24 https://doi.org/10.1111/j.1574-6976.1996.tb00251.x
  9. 이연희 : 항생제내성기전. 미생물과 산업 2002;28(2)29-34.
  10. Horii T, Arakawa Y, Ohta M, Ichiyama S, Wacharotayankun R, Kato N : Plasmid-mediated AmpC-type beta-lactamase isolated from Klebsiella pneumoniae confers resistance to broad-spectrum betalactams, including moxalactam. Antimicrob Agents Chemother 1993;37(5):984-990 https://doi.org/10.1128/AAC.37.5.984
  11. Cloeckaert A, Baucheron S, Flaujac G, Schwarz S, Kehrenberg C, Martel JL, Chaslus-Dancla E : Plasmid-mediated florfenicol resistance encoded by the floR gene in Escherichia coli isolated from cattle. Antimicrob Agents Chemother 2000;44(10):2858-2860 https://doi.org/10.1128/AAC.44.10.2858-2860.2000
  12. Simjee S, White DG, McDermott PF, Wagner DD, Zervos MJ, Donabedian SM, English LL, Hayes JR, Walker RD : Characterization of Tn1546 in vancomycin-resistant Enterococcus faecium isolated from canine urinary tract infections: evidence of gene exchange between human and animal enterococci. J Clin Microbiol 2002;40(12):4659-4665 https://doi.org/10.1128/JCM.40.12.4659-4665.2002
  13. Bauernfeind A, Wagner S, Jungwirth R, Schneider I, Meyer D : A novel class C beta-lactamase (FOX-2) in Escherichia coli conferring resistance to cephamycins. Antimicrob Agents Chemother 1997;41(9):2041-2046
  14. Nelson EC, Elisha BG : Molecular basis of AmpC hyperproduction in clinical isolates of Escherichia coli. Antimicrob Agents Chemother 1999;43(4):957-959
  15. Bonnet R, Chanal C, Ageron E, Sirot D, De Champs C, Grimont P, Sirot J : Inducible AmpC beta-lactamase of a new member Enterobacteriaceae. Antimicrob Agents Chemother 2002;46(10):3316-3319 https://doi.org/10.1128/AAC.46.10.3316-3319.2002
  16. Petrosino JF, Pendleton AR, Weiner JH, Rosenberg SM : Chromosomal system for studying AmpC-mediated beta-lactam resistance mutation in Escherichia coli. Antimicrob Agents Chemother 2002;46(5):1535-1539 https://doi.org/10.1128/AAC.46.5.1535-1539.2002
  17. Noguchi N, Emura A, Matsuyama H, O’Hara K, Sasatsu M, Kono M : Nucleotide sequence and characterization of erythromycin resistance determinant that encodes macrolide 2’-phosphotransferase I in Escherichia coli. Antimicrob Agents Chemother 1995;39(10):2359-2363 https://doi.org/10.1128/AAC.39.10.2359
  18. van Boxtel RA, van de Klundert JA : Expression of the Pseudomonas aeruginosa gentamicin resistance gene aacC3 in Escherichia coli. Antimicrob Agents Chemother 1998;42(12):3173-3178
  19. Furukawa H, Tsay JT, Jackowski S, Takamura Y, Rock CO : Thiolactomycin resistance in Escherichia coli is associated with the multidrug resistance efflux pump encoded by emrAB. J Bacteriol. 1993;175(12):3723-3729 https://doi.org/10.1128/jb.175.12.3723-3729.1993
  20. Gotoh N, Tsujimoto H, Poole K, Yamagishi J, Nishino T : The outer membrane protein OprM of Pseudomonas aeruginosa is encoded by oprK of the mexA-mexB-oprK multidrug resistance operon. Antimicrob Agents Chemother 1995;39(11):2567-2569 https://doi.org/10.1128/AAC.39.11.2567
  21. Hamzehpour MM, Pechere JC, Plesiat P, Kohler T : OprK and OprM define two genetically distinct multidrug efflux systems in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1995;39(11):2392-2396 https://doi.org/10.1128/AAC.39.11.2392
  22. Albertson GD, Niimi M, Cannon RD, Jenkinson HF : Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance. Antimicrob Agents Chemother 1996;40(12):2835-2841
  23. Mitchell BA, Brown MH, Skurray RA : QacA multidrug efflux pump from Staphylococcus aureus: comparative analysis of resistance to diamidines, biguanidines, and guanylhydrazones. Antimicrob Agents Chemother 1998;42(2):475-477 https://doi.org/10.1093/jac/42.4.475
  24. Kaatz GW, Seo SM, O’Brien L, Wahiduzzaman M, Foster TJ : Evidence for the existence of a multidrug efflux transporter distinct from NorA in Staphylococcus aureus. Antimicrob Agents Chemother 2000;44(5):1404-1406 https://doi.org/10.1128/AAC.44.5.1404-1406.2000
  25. Mazzariol A, Tokue Y, Kanegawa TM, Cornaglia G, Nikaido H : High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA. Antimicrob Agents Chemother 2001;45(2):647
  26. Yu JL, Grinius L, Hooper DC : NorA functions as a multidrug efflux protein in both cytoplasmic membrane vesicles and reconstituted proteoliposomes. J Bacteriol 2002;184(5):1370-1377 https://doi.org/10.1128/JB.184.5.1370-1377.2002